Perspective Therapeutics, Inc. (NYSE:CATX) Receives $12.50 Consensus PT from Analysts
Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) has received a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and three have given a strong buy rating to the […]
Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) has received a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and three have given a strong buy rating to the […]
